search
Back to results

Sleep Apnea, Obesity and Pregnancy (GOS)

Primary Purpose

Obesity, Pregnancy

Status
Completed
Phase
Not Applicable
Locations
France
Study Type
Interventional
Intervention
Polygraphic examination
Sponsored by
University Hospital, Rouen
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional diagnostic trial for Obesity focused on measuring pregnancy (after 30 weeks of amenorhea), obesity (BMI>35), sleep apnea syndrom, preeclampsy, intrauterine growth restriction

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)FemaleDoes not accept healthy volunteers

Inclusion Criteria:

  • BMI >35
  • Pregnancy after 30 Weeks of amenorhea
  • Age > 18
  • Signed consentment
  • Nationnal Health Program affiliation

Exclusion Criteria:

  • Twin or more pregnancy
  • Imprecise term
  • Artificial insemination with donor gametes
  • Proved thrombophilia
  • chronic renal failure
  • Previously treated (with CPAP) obstructive sleep apnea syndrom

Sites / Locations

  • Angers University Hospital
  • Caen University Hospital
  • Le Havre Hospital
  • Rouen University Hospital

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

Prevalence of obstructive sleep apnea syndrome

Arm Description

Determine the prevalence of obstructive sleep apnea syndrome (OSA) in late pregnancy in a population of obese patients . Polygraphic examination between 30 and 36 weeks of amenorhea

Outcomes

Primary Outcome Measures

Sleep apnea syndrom prevalence
Polygraphic examination for all subjects will determine the sleep apnea syndrom prevalence during late pregnancy (after 30 weeks of amenorhea) for severe obese women (BMI>35).

Secondary Outcome Measures

Full Information

First Posted
January 6, 2014
Last Updated
June 2, 2015
Sponsor
University Hospital, Rouen
search

1. Study Identification

Unique Protocol Identification Number
NCT02029859
Brief Title
Sleep Apnea, Obesity and Pregnancy
Acronym
GOS
Official Title
Sleep Apnea, Obesity and Pregnancy
Study Type
Interventional

2. Study Status

Record Verification Date
June 2015
Overall Recruitment Status
Completed
Study Start Date
April 2011 (undefined)
Primary Completion Date
July 2014 (Actual)
Study Completion Date
March 2015 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University Hospital, Rouen

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
Main objective: Determine the prevalence of obstructive sleep apnea syndrome (OSA) in late pregnancy in a population of obese patients . Secondary objectives : Identify risk factors for OSA during pregnancy (age, parity, high blood pressure, snoring , weight, neck circumference, scores on symptoms of sleep apnea, ... ) . Compare perinatal morbidity among obese patients with OSA in late pregnancy with case-controls. Evaluate the evolution of a moderate or severe OSA 6 months after pregnancy. Material and methods Characteristics of the study: Interventional biomedical research Prospective Multicenter nonrandomized study Flow chart Patients will be included between 30 and 36 weeks of amenorrhea (WA) . Will rated from inclusion: age, parity, weight, height, BMI in early pregnancy, neck circumferrence, treated high blood pressure. As recommended in France, the main test results during the pregnancy follow-up will be recorded. At the inclusion visit will be conducted a Berlin Questionnaire and Epworth Score. Screening for OSA by nocturnal polysomnography will be performed between 30 and 36WA. This screening can be performed as an outpatient. In case of proven OSA patients will be offered an appropriate care by today's standards. Whatever the outcome of pregnancy, a second polysomnography will be performed 6 months after childbirth in case of OSA during pregnancy.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Obesity, Pregnancy
Keywords
pregnancy (after 30 weeks of amenorhea), obesity (BMI>35), sleep apnea syndrom, preeclampsy, intrauterine growth restriction

7. Study Design

Primary Purpose
Diagnostic
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
205 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Prevalence of obstructive sleep apnea syndrome
Arm Type
Experimental
Arm Description
Determine the prevalence of obstructive sleep apnea syndrome (OSA) in late pregnancy in a population of obese patients . Polygraphic examination between 30 and 36 weeks of amenorhea
Intervention Type
Procedure
Intervention Name(s)
Polygraphic examination
Intervention Description
Polygraphic examination between 30 and 36 weeks of amenorhea
Primary Outcome Measure Information:
Title
Sleep apnea syndrom prevalence
Description
Polygraphic examination for all subjects will determine the sleep apnea syndrom prevalence during late pregnancy (after 30 weeks of amenorhea) for severe obese women (BMI>35).
Time Frame
6 weeks

10. Eligibility

Sex
Female
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: BMI >35 Pregnancy after 30 Weeks of amenorhea Age > 18 Signed consentment Nationnal Health Program affiliation Exclusion Criteria: Twin or more pregnancy Imprecise term Artificial insemination with donor gametes Proved thrombophilia chronic renal failure Previously treated (with CPAP) obstructive sleep apnea syndrom
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Loic Marpeau, PHD
Organizational Affiliation
Rouen University Hospital
Official's Role
Principal Investigator
Facility Information:
Facility Name
Angers University Hospital
City
Angers
ZIP/Postal Code
49000
Country
France
Facility Name
Caen University Hospital
City
Caen
ZIP/Postal Code
14000
Country
France
Facility Name
Le Havre Hospital
City
Le Havre
ZIP/Postal Code
76290
Country
France
Facility Name
Rouen University Hospital
City
Rouen
ZIP/Postal Code
76000
Country
France

12. IPD Sharing Statement

Learn more about this trial

Sleep Apnea, Obesity and Pregnancy

We'll reach out to this number within 24 hrs